Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) FCF Payout Ratio: 10.36%

Is Zimmer Biomet Holdings, Inc.’s FCF payout ratio high or low?

Zimmer Biomet Holdings, Inc.'s FCF payout ratio of 10.36% is 37% below its 5-year average of 16.48%, near the low end of its 5-year range (10.36%–18.85%).

31.11% below its 12-month average of 15.04%.

ZBH FCF Payout Ratio Chart

ZBH FCF Payout Ratio
12.92%-24.66% 1Y
Zoom

ZBH Average FCF Payout Ratio Chart

ZBH Current vs Average FCF Payout Ratio Chart

ZBH FCF Payout Ratio Metrics

FCF PAYOUT RATIO

10.36%

FCF PAYOUT RATIO AVG TTM

15.04%

FCF PAYOUT RATIO AVG 3Y

16.46%

FCF PAYOUT RATIO AVG 5Y

16.48%

FCF PAYOUT RATIO AVG 10Y

16.13%

FCF PAYOUT RATIO AVG 15Y

15.56%

FCF PAYOUT RATIO AVG 20Y

15.56%

CURRENT VS TTM AVG

-31.11%

CURRENT VS 3Y AVG

-37.07%

CURRENT VS 5Y AVG

-37.13%

CURRENT VS 10Y AVG

-35.79%

CURRENT VS 15Y AVG

-33.41%

CURRENT VS 20Y AVG

-33.41%

Payout Ratio Comparison

FCF Payout Ratio

10.4%

Earnings Payout Ratio

27.0%

Dividend Yield

1.09%

FCF Yield

10.66%

Annual FCF Payout Ratio History

YearFree Cash FlowDividends PaidFCF Payout Ratio
2025$1.47B$190.30M12.9%
2024$1.14B$196.00M17.2%
2023$1.19B$200.90M16.9%
2022$1.07B$201.20M18.9%
2021$1.35B$200.10M14.9%
2020$1.09B$198.50M18.2%
2019$1.18B$196.70M16.7%
2018$1.58B$195.20M12.3%
2017$1.43B$193.60M13.6%
2016$1.45B$188.40M13.0%
2015$682.10M$157.10M23.0%
2014$915.60M$145.50M15.9%
2013$863.10M$132.40M15.3%
2012$1.04B$94.40M9.1%
2011$1.06B$510.40M48.0%
2010$1.11B$00.0%
2009$852.90M$00.0%
2008$440.80M$00.0%
2007$753.20M$00.0%
2006$772.40M$00.0%
2005$772.90M$00.0%
2004$761.40M$00.0%
2003$336.30M$00.0%
2002$186.50M$00.0%
2001$117.10M$290.00M247.7%
2000$203.40M$00.0%
1999$147.00M$00.0%
1998$179.00M$00.0%

Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100

FCF payout and earnings payout:

  • FCF represents operating cash flow after capital expenditures
  • FCF payout compares dividends paid with free cash flow
  • FCF payout above 100% means dividends paid exceeded free cash flow for the period
  • Earnings payout compares dividends paid with net income

Reading the series: Use the chart and table to compare dividend payments with cash generation over time.

Zimmer Biomet Holdings, Inc. FCF Payout Ratio Formula & Definition

FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zimmer Biomet Holdings, Inc. FCF Payout Ratio FAQ

What is the FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The FCF payout ratio for ZBH stock is 10.36%.
Is Zimmer Biomet Holdings, Inc.'s FCF payout ratio high or low?
Zimmer Biomet Holdings, Inc.'s FCF payout ratio of 10.36% is 37% below its 5-year average of 16.48%, near the low end of its 5-year range (10.36%–18.85%).
What is the TTM average FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The TTM average FCF payout ratio for ZBH stock is 15.04%.
What is the 3Y average FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 3Y average FCF payout ratio for ZBH stock is 16.46%.
What is the 5Y average FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 5Y average FCF payout ratio for ZBH stock is 16.48%.
What is the 10Y average FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 10Y average FCF payout ratio for ZBH stock is 16.13%.
What is the 15Y average FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 15Y average FCF payout ratio for ZBH stock is 15.56%.
What is the 20Y average FCF payout ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 20Y average FCF payout ratio for ZBH stock is 15.56%.

Zimmer Biomet Holdings, Inc. FCF Payout Ratio History

DATEFCF PAYOUT RATIO
2025-12-3112.92%
2024-12-3117.15%
2023-12-3116.92%
2022-12-3118.85%
2021-12-3114.85%
2020-12-3118.17%
2019-12-3116.65%
2018-12-3112.32%
2017-12-3113.57%
2016-12-3113.02%
2015-12-3123.03%
2014-12-3115.89%
2013-12-3115.34%
2012-12-319.10%
2011-12-3148.01%
2001-12-31247.65%

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos